Showing results (711-720 of 816) with videos related to

Sort By:
Pageof 82
Blood|September 15, 1992
Specific marrow ablation before marrow transplantation using an aminophosphonic acid conjugate 166Ho-EDTMPF R Appelbaum, P A Brown, B M Sandmaier, et al.
Bone Marrow Transplantation|January 1, 1992
Is there a better way to deliver total body irradiation?F R Appelbaum, C C Badger, I D Bernstein, et al.
Leukemia|March 18, 2005
High doses of transplanted CD34+ cells are associated with rapid T-cell engraftment and lessened risk of graft rejection, but not more graft-versus-host disease after nonmyeloablative conditioning and unrelated hematopoietic cell transplantationF Baron, M B Maris, B E Storer, et al.
Bone Marrow Transplantation|July 1, 1992
Etoposide, cyclophosphamide and fractionated total body irradiation as a preparative regimen for marrow transplantation in patients with advanced hematological malignancies: a phase I studyF B Petersen, C D Buckner, F R Appelbaum, et al.
Lancet (London, England)|September 18, 1982
Treatment of chronic granulocytic leukaemia in chronic phase by allogeneic marrow transplantationR A Clift, C D Buckner, E D Thomas, et al.
Bone Marrow Transplantation|November 1, 1989
Busulfan, cyclophosphamide and fractionated total body irradiation as a preparatory regimen for marrow transplantation in patients with advanced hematological malignancies: a phase I studyF B Petersen, C D Buckner, F R Appelbaum, et al.
Blood|August 1, 1981
Recovery of antibody production in human allogeneic marrow graft recipients: influence of time posttransplantation, the presence or absence of chronic graft-versus-host disease, and antithymocyte globulin treatmentR P Witherspoon, R Storb, H D Ochs, et al.
Blood|December 12, 2001
Administration of cyclosporine for 24 months compared with 6 months for prevention of chronic graft-versus-host disease: a prospective randomized clinical trialE Kansu, T Gooley, M E Flowers, et al.
Blood|December 1, 1988
HLA-identical marrow transplantation during accelerated-phase chronic myelogenous leukemia: analysis of survival and remission durationP J Martin, R A Clift, L D Fisher, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 1, 1996
Marrow transplantation for hepatitis-associated aplastic anemia: a follow-up of long-term survivorsH P Kiem, G B McDonald, D Myerson, et al.
Pageof 82